Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 1/2016

01-02-2016

Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit

Authors: Carol A. Rosenberg, Carol Flanagan, Bruce Brockstein, Jennifer C. Obel, Leon H. Dragon, Douglas E. Merkel, Elaine L. Wade, Teresa M. Law, Janardan D. Khandekar, Thomas A. Hensing

Published in: Journal of Cancer Survivorship | Issue 1/2016

Login to get access

Abstract

Purpose

The LIFE Cancer Survivorship Program at NorthShore University HealthSystem provides risk-adapted visits (RAV) facilitated by an oncology nurse during which a survivorship care plan (SCP) is provided and discussed. In this report, we describe and evaluate RAV in promoting individualized health care and self-management during survivorship transition.

Methods

Patients complete a post-RAV questionnaire at their RAV and another ≥1 year after their RAV.

Results

One thousand seven hundred thirteen (1713) RAVs, majority for breast cancer, occurred from January 2007 to March 2014. One thousand six hundred fifteen (1615) “day-of” post-RAV questionnaires were completed. Respondents scaled statements as strongly agree/agree/disagree/strongly disagree. Combined strongly agree/agree ratings are 94 % felt more confident in communicating information about their treatments to other health care providers, 90 % felt more comfortable recognizing signs/symptoms to report to providers, and 98 % had a better appreciation for community programs/services. Of 488 respondents (RAV January 2007 to December 2012 n = 1366) to a questionnaire at least 1 year after the RAV, nearly 100 % found SCP useful to summarize medical information, 97 % to reinforce follow-up, 85 % to recognize symptoms of recurrence, 93 % to identify healthy lifestyle practices, 91 % to assist in identifying resources for support, 72 % discussed their SCP with their healthcare provider, and 97 % made at least one positive lifestyle change.

Conclusions

Participation in LIFE RAV following treatment helps survivors to guide future self-care behavior. Data suggest that benefits may persist 1 year after the visit and support the feasibility of a nurse-led RAV to establish a SCP in cancer survivors.

Implications for Cancer Survivors

Combined provision and discussion of SCPs help survivors construct a useful understanding of their cancer experience and may promote long-term self-management.
Appendix
Available only for authorised users
Literature
1.
Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington DC: Institute of Medicine and National Research Council of the National Academies, National Academies Press; 2005.
2.
3.
McCabe M, Bhatia S, Oeffinger K, Reaman GH, Tyne C, Wolins DS, et al. American society of clinical oncology statement: achieving high quality cancer survivorship care. J Clin Oncol. 2013;31:631–20.PubMedCrossRef
4.
Parekh AK, Kronick R, Tavenner M. Optimizing health for persons with multiple chronic conditions. JAMA. 2014;312:1199–200.PubMedCrossRef
5.
Davies NJ, Batehup L. Towards a personalized approach to aftercare: a review of cancer follow-up in the UK. J Cancer Surviv. 2011;5:142–51.PubMedCrossRef
6.
Loprinzi PD, Cardinal BJ, Si Q, Bennett JA, Winters-Stone M. Theory based predictors of follow-up exercise behavior after a supervised exercise intervention in older breast cancer survivors. Support Care Cancer. 2012;20:2511–21.PubMedPubMedCentralCrossRef
7.
Anderson AS, Steele R, Coyle J. Lifestyle issues for colorectal cancer survivors-perceived needs, beliefs and opportunities. Support Care Cancer. 2013;21:35–42.PubMedCrossRef
8.
Nissen MJ, Tsai ML, Blaes AH, Swenson KK, Koering S. Effectiveness of treatment summaries in increasing breast and colorectal cancer survivors’ knowledge about their diagnosis and treatment. J Cancer Surviv. 2013;7:211–8.PubMedCrossRef
9.
Boyajian RN, Grose A, Grenon N, Roper K, Sommer K, Walsh M, et al. Desired elements and timing of cancer survivorship care: one approach may not fit all. J Oncol Pract. 2014;10:e293–8.PubMedCrossRef
10.
Snyder CF, Herman JM, White SM, Luber BS, Blackford AL, Carducci MA, et al. When using patient reported outcomes in clinical practice the measure matters: a randomized controlled trial. J Oncol Pract. 2014;10:e299–306.PubMedPubMedCentralCrossRef
11.
Salz T, Baxi SS, Blinder VS, Elkin EB, Kemeny MM, McCabe MS, et al. Colorectal cancer survivors’ need and preferences for survivorship information. J Oncol Pract. 2014;10:e277–82.PubMedPubMedCentralCrossRef
12.
13.
Baker R, Denniston M, Smith T, West M. Adult cancer survivors: How are they fairing at about a year after diagnosis? Cancer. 2005;104(11):2565–76.PubMedCrossRef
14.
Mayer DK, Nekhlyudov L, Snyder CF, Merrill JK, Wollins DS, Shulman LN. American society of clinical oncology clinical expert statement on cancer survivorship care planning. J Oncol Pract. 2014;10:345–51.PubMedCrossRef
15.
Dulko D, Pace CM, Dittus KL, Sprague BL, Pollack LA, Hawkins NA, et al. Barriers and facilitators to implementing cancer survivorship care plans. Oncol Nurs Forum. 2013;40:573–80.CrossRef
16.
17.
Shaw RJ, McDuffie JR, Hendrix CC, Edie A, Lindsey-Davis L, Nagi A, et al. Effects of nurse-managed protocols in the outpatient management of adults with chronic conditions: a systematic review and meta-analysis. Ann Intern Med. 2014;161:113–21.PubMedCrossRef
18.
Cooper C, Depledge J. Cytotoxic chemotherapy: what do community nurses need to know? Brit J Comm Nurs. 2004;9:26–32.CrossRef
19.
Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA. Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physician and medical oncologist in the United States. J Clin Oncol. 2013;31:2322–36.PubMedPubMedCentralCrossRef
20.
Forsythe LP, Parry C, Alfano CM, Kent EE, Leach CR, Haggstrom DA, et al. Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst. 2013;106:1579–87.CrossRef
21.
22.
Blanch-Hartigan D, Forsythe LP, Alfano CM, Smith T, Nekhlyudov L, Ganz PA, et al. Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologist and primary care physicians. J Clin Oncol. 2014;32:1578–85.PubMedPubMedCentralCrossRef
23.
24.
Demark-Wahnefried W, Aziz NM, Rowland JH. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23:5814–30.PubMedPubMedCentralCrossRef
25.
26.
27.
Kushi LH, Doyle C, McCullough M, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA Cancer J Clin. 2012;62:30–67.PubMedCrossRef
28.
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwarz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62:242–74.CrossRef
29.
Denlinger CS, Ligibel JA, Are M, Baker S, Demark-Wahnefried W, Dzon D, et al. NCCN survivorship: healthy lifestyles, version 2.2014. J Natl Compr Cancer Netw. 2014;12:1222–37.
30.
Denlinger CS, Ligibel JA, Are M, Baker S, Demark-Wahnefried W, Dzon D, et al. NCCN survivorship: nutrition and weight management, version 2. Natl Compr Cancer Netw. 2014;12:1396–406.
31.
Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32:3568–74.PubMedCrossRef
32.
Fortmann SP, Burda BU, Senger CA, Lin JS, Whilock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an update systematic evidence review for the U. S. Preventive Services Task Force. Ann Intern Med. 2013;159:824–34.PubMedCrossRef
33.
Guallar E, Stranges S, Mulrow C, Appel LJ, Miller ER. Stop wasting money on vitamin and mineral supplements. Ann Intern Med. 2013;159:850–1.PubMedCrossRef
34.
Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627–35.PubMedCrossRef
35.
Ballard-Barbash R, Friedenreich CM, Courneya KS, et al. Physical activity, biomarkers and disease outcomes in cancer survivors; a systematic review. J Natl Cancer Inst. 2012;104:815–40.PubMedPubMedCentralCrossRef
36.
Bradshaw PT, Ibahim JG, Stevens J, et al. Post diagnosis change in body weight and survival after breast cancer diagnosis. Epidemiology. 2012;23:320–7.PubMedPubMedCentralCrossRef
37.
Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293:2479–86.PubMedCrossRef
38.
Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006;24:3535–41.PubMedCrossRef
39.
Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24:3527–34.PubMedCrossRef
40.
Demark-Wahnefried W. Cancer survival: time to get moving: data accumulate suggesting a link between physical activity and cancer survival. J Clin Oncol. 2006;24:3517–8.PubMedPubMedCentralCrossRef
41.
Richman EL, Kenfield SA, Stampfer MJ, et al. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011;71:3889–95.PubMedPubMedCentralCrossRef
42.
Irwin ML. Weight loss interventions and breast cancer survival: the time is now. J Clin Oncol. 2014;32:2197–9.PubMedCrossRef
43.
Irwin ML , Carmel B, Gross C, Ercolano E, Li F, Yao X, Fiellin M, Capozza S, Rothbard M, Zhou Y, Harrigan M, Sanft T, Schmitz K, Neogi T, Hershman D, Ligibel J. Randomized trial of exercise vs. usual care on aromatase-inhibitor side effects in breast cancer survivors. J Oncol Pract. 2014; doi: 10.​1200/​JCO.​2014.​57
44.
Ness S, Kokal J, Fee-Shroeder K, Novotny P, Satele D, Barton D. Concerns across the survivorship trajectory. Results from a survey of cancer survivors. Oncol Nurs Forum. 2013;40:35–42.PubMedCrossRef
45.
Halpern MT, Viswanathan M, Evans TS, Birken SA, Basch E, Mayer DK. Models of cancer survivorship care: overview and summary of current evidence. J Oncol Pract. 2015;11:e19–27.CrossRef
46.
Ganz PA, Yip CH, Gralow JR, Distelhorst SR, Albain KS, Andersen BL, et al. Supportive +care after curative treatment for breast cancer (survivor care): resource allocations in low-and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013;22:606–15.PubMedCrossRef
47.
Parry C, Kent EE, Forsythe LP, Alfano CM, Rowland JH. Can’t see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol. 2013;31:2651–3.PubMedPubMedCentralCrossRef
48.
Earle CC, Ganz PA. Cancer survivorship care: don’t’ let the perfect be the enemy of good. J Clin Oncol. 2012;30:3764–8.PubMedCrossRef
49.
Metadata
Title
Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit
Authors
Carol A. Rosenberg
Carol Flanagan
Bruce Brockstein
Jennifer C. Obel
Leon H. Dragon
Douglas E. Merkel
Elaine L. Wade
Teresa M. Law
Janardan D. Khandekar
Thomas A. Hensing
Publication date
01-02-2016
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2016
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0467-6

Other articles of this Issue 1/2016

Journal of Cancer Survivorship 1/2016 Go to the issue

OriginalPaper

Smoking behavior among adult childhood cancer survivors: what are we missing?

OriginalPaper

Satisfaction with information and unmet information needs in men and women with cancer

OriginalPaper

Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case–control study

OriginalPaper

Incidence of second primary cancers in North Portugal—a population-based study

OriginalPaper

Physical inactivity and risk of poor quality of life among elderly cancer survivors compared to women without cancer: the Iowa Women’s Health Study

OriginalPaper

Social-ecological correlates of physical activity in kidney cancer survivors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits